Hun-Sik Wang
Chief Executive Officer chez GL PHARM TECH CORP.
Fortune : 1 M $ au 31/03/2024
Profil
Hun-Sik Wang is currently the Chief Executive Officer and Director at GL Pharm Tech Corp.
Prior to this, he was the Chief Executive Officer at GL PharmTech, Inc. and Co-Chief Executive Officer at Crown Pharm Co., Ltd.
He holds a doctorate degree from Chungnam National University and a graduate degree from Chung-Ang University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GL PHARM TECH CORP.
1,30% | 06/03/2024 | 993 323 ( 1,30% ) | 1 M $ | 31/03/2024 |
Postes actifs de Hun-Sik Wang
| Sociétés | Poste | Début |
|---|---|---|
| GL PHARM TECH CORP. | Chief Executive Officer | 01/08/2002 |
Anciens postes connus de Hun-Sik Wang
| Sociétés | Poste | Fin |
|---|---|---|
Crown Pharm Co., Ltd.
 Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Chief Executive Officer | - |
GL PharmTech, Inc. /Old/
 GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Chief Executive Officer | - |
Formation de Hun-Sik Wang
| Chungnam National University | Doctorate Degree |
| Chung-Ang University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GL PHARM TECH CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GL PharmTech, Inc. /Old/
GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Health Technology |
Crown Pharm Co., Ltd.
Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Health Technology |
